Share & Key figures
Marinomed Biotech AG has been listed on the Vienna Stock Exchange since 1 February 2019. The shares are listed in the Prime Market segment and included in the ATX Prime Index.
| Share data | |
| ISIN | ATMARINOMED6 |
| Share class | No-par bearer shares |
| Nominal capital | EUR 1,469,772 (1,469,772 no-par value shares) |
| Ticker symbol | MARI |
| Issue price (IPO) on 1.2.2019 | EUR 75.00 |
| Market capitalization (at issue price) | EUR 97.4 Mio. |
For current price information please follow the link to the website of the Vienna Stock Exchange.
Coverage
Erste Group (Vladimira Urbankova)
goetzpartners securities Limited (Brigitte de Lima)
| Selected key financial figures | ||
| in EUR Mio. | 2018 | 2017 |
| Revenues | 4.67 | 4.81 |
| Operating result (EBIT) | -5.14 | -1.64 |
| Loss for the year | -12.10 | -2.38 |
| Adjusted annual result 1) | -4.56 | |
| Cash and cash equivalents per 31.12. | 1.72 | 6.03 |
| Balance sheet total per 31.12. | 5.26 | 9.33 |
| Net cash flow | -4.31 | 4.02 |
1) Adjusted annual result, excluding one-off special effects (valuation of the convertible bond and IPO costs)